These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 30883338)

  • 1. Immunohistochemical assessment of cyclin D1 and p53 is associated with survival in childhood malignant peripheral nerve sheath tumor.
    Krawczyk MA; Karpinsky G; Izycka-Swieszewska E; Gabrych A; Kunc M; Fatyga A; Garstka M; Styczewska M; Sokolewicz EM; Szlagatys-Sidorkiewicz A; Kazanowska B; Bien E
    Cancer Biomark; 2019; 24(3):351-361. PubMed ID: 30883338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor expression of survivin, p53, cyclin D1, osteopontin and fibronectin in predicting the response to neo-adjuvant chemotherapy in children with advanced malignant peripheral nerve sheath tumor.
    Karpinsky G; Krawczyk MA; Izycka-Swieszewska E; Fatyga A; Budka A; Balwierz W; Sobol G; Zalewska-Szewczyk B; Rychlowska-Pruszynska M; Klepacka T; Dembowska-Baginska B; Kazanowska B; Gabrych A; Bien E
    J Cancer Res Clin Oncol; 2018 Mar; 144(3):519-529. PubMed ID: 29332262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survivin expression and prognostic significance in pediatric malignant peripheral nerve sheath tumors (MPNST).
    Alaggio R; Turrini R; Boldrin D; Merlo A; Gambini C; Ferrari A; Dall'igna P; Coffin CM; Martines A; Bonaldi L; De Salvo GL; Zanovello P; Rosato A
    PLoS One; 2013; 8(11):e80456. PubMed ID: 24303016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical, pathological, and molecular variables predictive of malignant peripheral nerve sheath tumor outcome.
    Zou C; Smith KD; Liu J; Lahat G; Myers S; Wang WL; Zhang W; McCutcheon IE; Slopis JM; Lazar AJ; Pollock RE; Lev D
    Ann Surg; 2009 Jun; 249(6):1014-22. PubMed ID: 19474676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric malignant peripheral nerve sheath tumor: the Italian and German soft tissue sarcoma cooperative group.
    Carli M; Ferrari A; Mattke A; Zanetti I; Casanova M; Bisogno G; Cecchetto G; Alaggio R; De Sio L; Koscielniak E; Sotti G; Treuner J
    J Clin Oncol; 2005 Nov; 23(33):8422-30. PubMed ID: 16293873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of p53 as a strong predictor of survival for patients with malignant peripheral nerve sheath tumors.
    Brekke HR; Kolberg M; Skotheim RI; Hall KS; Bjerkehagen B; Risberg B; Domanski HA; Mandahl N; Liestøl K; Smeland S; Danielsen HE; Mertens F; Lothe RA
    Neuro Oncol; 2009 Oct; 11(5):514-28. PubMed ID: 19182148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 and Ki-67 proliferating cell nuclear antigen in benign and malignant peripheral nerve sheath tumors in children.
    Liapis H; Marley EF; Lin Y; Dehner LP
    Pediatr Dev Pathol; 1999; 2(4):377-84. PubMed ID: 10347283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and molecular prognostic predictors of malignant peripheral nerve sheath tumor.
    Fan Q; Yang J; Wang G
    Clin Transl Oncol; 2014 Feb; 16(2):191-9. PubMed ID: 23749326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of AKT/mTOR and MAPK pathways and antitumor effect of mTOR inhibitor in NF1-related and sporadic malignant peripheral nerve sheath tumors.
    Endo M; Yamamoto H; Setsu N; Kohashi K; Takahashi Y; Ishii T; Iida K; Matsumoto Y; Hakozaki M; Aoki M; Iwasaki H; Dobashi Y; Nishiyama K; Iwamoto Y; Oda Y
    Clin Cancer Res; 2013 Jan; 19(2):450-61. PubMed ID: 23209032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant peripheral nerve sheath tumours: high Ki67 labelling index is the significant prognostic indicator.
    Watanabe T; Oda Y; Tamiya S; Kinukawa N; Masuda K; Tsuneyoshi M
    Histopathology; 2001 Aug; 39(2):187-97. PubMed ID: 11493336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant peripheral nerve sheath tumors in children, adolescents, and young adults: Treatment results of five Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry.
    Meister MT; Scheer M; Hallmen E; Stegmaier S; Vokuhl C; von Kalle T; Fuchs J; Münter M; Niggli F; Ladenstein R; Kazanowska B; Ljungman G; Bielack S; Koscielniak E; Klingebiel T;
    J Surg Oncol; 2020 Dec; 122(7):1337-1347. PubMed ID: 32812260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptosis, proliferation and p53, cyclin D1, and retinoblastoma gene expression in relation to radiation response in transitional cell carcinoma of the bladder.
    Moonen L; Ong F; Gallee M; Verheij M; Horenblas S; Hart AA; Bartelink H
    Int J Radiat Oncol Biol Phys; 2001 Apr; 49(5):1305-10. PubMed ID: 11286838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MMP-13 and p53 in the progression of malignant peripheral nerve sheath tumors.
    Holtkamp N; Atallah I; Okuducu AF; Mucha J; Hartmann C; Mautner VF; Friedrich RE; Mawrin C; von Deimling A
    Neoplasia; 2007 Aug; 9(8):671-7. PubMed ID: 17786186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinicopathological features and prognosis of malignant peripheral nerve sheath tumor: a retrospective study of 140 cases].
    Yuan ZN; Xu LB; Zhao ZG; Xu SF; Zhang XX; Liu T; Zhang SG; Yu SJ
    Zhonghua Zhong Liu Za Zhi; 2017 Jun; 39(6):439-444. PubMed ID: 28635234
    [No Abstract]   [Full Text] [Related]  

  • 15. p53, Ki67 and cyclin D1 as prognosticators of lymph node metastases in laryngeal carcinoma.
    Mielcarek-Kuchta D; Olofsson J; Golusinski W
    Eur Arch Otorhinolaryngol; 2003 Nov; 260(10):549-54. PubMed ID: 14551784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Array-based comparative genomic hybridization identifies CDK4 and FOXM1 alterations as independent predictors of survival in malignant peripheral nerve sheath tumor.
    Yu J; Deshmukh H; Payton JE; Dunham C; Scheithauer BW; Tihan T; Prayson RA; Guha A; Bridge JA; Ferner RE; Lindberg GM; Gutmann RJ; Emnett RJ; Salavaggione L; Gutmann DH; Nagarajan R; Watson MA; Perry A
    Clin Cancer Res; 2011 Apr; 17(7):1924-34. PubMed ID: 21325289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 expression in neurofibroma and malignant peripheral nerve sheath tumor. An immunohistochemical study of sporadic and NF1-associated tumors.
    Halling KC; Scheithauer BW; Halling AC; Nascimento AG; Ziesmer SC; Roche PC; Wollan PC
    Am J Clin Pathol; 1996 Sep; 106(3):282-8. PubMed ID: 8816583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1: a clinicopathologic and molecular study of 17 patients.
    Leroy K; Dumas V; Martin-Garcia N; Falzone MC; Voisin MC; Wechsler J; Revuz J; Créange A; Levy E; Lantieri L; Zeller J; Wolkenstein P
    Arch Dermatol; 2001 Jul; 137(7):908-13. PubMed ID: 11453810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular markers for predicting prostate cancer stage and survival.
    Dunsmuir WD; Gillett CE; Meyer LC; Young MP; Corbishley C; Eeles RA; Kirby RS
    BJU Int; 2000 Nov; 86(7):869-78. PubMed ID: 11069416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1.
    Fang Y; Elahi A; Denley RC; Rao PH; Brennan MF; Jhanwar SC
    Anticancer Res; 2009 Apr; 29(4):1255-62. PubMed ID: 19414372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.